Published in PLoS One on October 15, 2013
High rates of virological suppression in a cohort of human immunodeficiency virus-positive adults receiving antiretroviral therapy in ethiopian health centers irrespective of concomitant tuberculosis. Open Forum Infect Dis (2014) 0.81
The effect of tuberculosis treatment on virologic and immunologic response to combination antiretroviral therapy among South African children. J Acquir Immune Defic Syndr (2014) 0.78
Bias in meta-analysis detected by a simple, graphical test. BMJ (1997) 122.24
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med (2009) 65.36
Operating characteristics of a rank correlation test for publication bias. Biometrics (1994) 47.97
Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet (2006) 31.79
Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics (2000) 19.26
Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes. JAMA (2006) 17.93
Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS (2008) 13.25
Timing of initiation of antiretroviral drugs during tuberculosis therapy. N Engl J Med (2010) 10.90
Explaining heterogeneity in meta-analysis: a comparison of methods. Stat Med (1999) 9.40
Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis. PLoS One (2009) 8.58
Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis. N Engl J Med (2011) 7.13
Timing of antiretroviral therapy for HIV-1 infection and tuberculosis. N Engl J Med (2011) 6.42
The mortality and pathology of HIV infection in a west African city. AIDS (1993) 6.08
Risk factors for high early mortality in patients on antiretroviral treatment in a rural district of Malawi. AIDS (2006) 5.87
A re-evaluation of random-effects meta-analysis. J R Stat Soc Ser A Stat Soc (2009) 5.81
Seven-year experience of a primary care antiretroviral treatment programme in Khayelitsha, South Africa. AIDS (2010) 5.46
Integration of antiretroviral therapy with tuberculosis treatment. N Engl J Med (2011) 5.31
Asymptomatic serum cryptococcal antigenemia and early mortality during antiretroviral therapy in rural Uganda. Trop Med Int Health (2007) 3.69
Tuberculosis during the first year of antiretroviral therapy in a South African cohort using an intensive pretreatment screening strategy. AIDS (2010) 2.90
Autopsy study of HIV-1-positive and HIV-1-negative adult medical patients in Nairobi, Kenya. J Acquir Immune Defic Syndr (2000) 2.86
Outcomes of nevirapine- and efavirenz-based antiretroviral therapy when coadministered with rifampicin-based antitubercular therapy. JAMA (2008) 2.45
Strategies to reduce early morbidity and mortality in adults receiving antiretroviral therapy in resource-limited settings. Curr Opin HIV AIDS (2010) 2.14
Effect of isoniazid prophylaxis on mortality and incidence of tuberculosis in children with HIV: randomised controlled trial. BMJ (2006) 2.13
Causes of death on antiretroviral therapy: a post-mortem study from South Africa. PLoS One (2012) 1.99
Similar mortality and reduced loss to follow-up in integrated compared with vertical programs providing antiretroviral treatment in sub-saharan Africa. J Acquir Immune Defic Syndr (2012) 1.58
Effect of pulmonary tuberculosis on mortality in patients receiving HAART. AIDS (2009) 1.56
Very early mortality in patients starting antiretroviral treatment at primary health centres in rural Malawi. Trop Med Int Health (2009) 1.51
Cause of death and presence of respiratory disease at autopsy in an HIV-1 seroconversion cohort of southern African gold miners. AIDS (2007) 1.48
The effect of tuberculosis on mortality in HIV positive people: a meta-analysis. PLoS One (2010) 1.46
Youth, unemployment, and male gender predict mortality in AIDS patients started on HAART in Nigeria. AIDS Care (2009) 1.43
Association of age with mortality and virological and immunological response to antiretroviral therapy in rural South African adults. PLoS One (2011) 1.43
Outcomes of tuberculosis patients who start antiretroviral therapy under routine programme conditions in Malawi. Int J Tuberc Lung Dis (2007) 1.36
Prevalent and incident tuberculosis are independent risk factors for mortality among patients accessing antiretroviral therapy in South Africa. PLoS One (2013) 1.35
Determinants of early and late mortality among HIV-infected individuals receiving home-based antiretroviral therapy in rural Uganda. J Acquir Immune Defic Syndr (2011) 1.21
Hyponatremia, hypochloremia, and hypoalbuminemia predict an increased risk of mortality during the first year of antiretroviral therapy among HIV-infected Zambian and Kenyan women. AIDS Res Hum Retroviruses (2011) 1.19
Loss to follow-up and mortality among HIV-infected people co-infected with TB at ART initiation in Durban, South Africa. J Acquir Immune Defic Syndr (2012) 1.17
Mortality in the year following antiretroviral therapy initiation in HIV-infected adults and children in Uganda and Zimbabwe. Clin Infect Dis (2012) 1.07
Systematic underestimation of treatment effects as a result of diagnostic test inaccuracy: implications for the interpretation and design of thromboprophylaxis trials. Thromb Haemost (1995) 0.95
Active tuberculosis is associated with worse clinical outcomes in HIV-infected African patients on antiretroviral therapy. PLoS One (2013) 0.95
Treatment outcomes of patients co-infected with HIV and tuberculosis who received a nevirapine-based antiretroviral regimen: a four-year prospective study. Int J Infect Dis (2010) 0.94
Risk factors for mortality among HIV-positive patients with and without active tuberculosis in Dar es Salaam, Tanzania. Antivir Ther (2011) 0.94
Management of tuberculosis in HIV-infected patients. AIDS Rev (2012) 0.92
Predictors of mortality among HIV-infected patients initiating anti retroviral therapy at a tertiary care hospital in eastern India. Asian Pac J Trop Med (2012) 0.92
Prevalent tuberculosis and mortality among HAART initiators. AIDS (2012) 0.87
Response to HAART in treatment-naive HIV-infected patients with a prior diagnosis of tuberculosis or other opportunistic infections. Curr HIV Res (2011) 0.87
Treatment for tuberculosis-associated immune reconstitution inflammatory syndrome in 34 HIV-infected patients. Int J Tuberc Lung Dis (2012) 0.86
Viral decay rates are similar in HIV-infected patients with and without TB coinfection during treatment with an Efavirenz-based regimen. Clin Infect Dis (2011) 0.81
Neighborhood characteristics associated with the location of food stores and food service places. Am J Prev Med (2002) 13.39
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. PLoS Med (2007) 10.43
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Ann Intern Med (2007) 7.87
Rethinking the heterosexual infectivity of HIV-1: a systematic review and meta-analysis. Lancet Infect Dis (2008) 5.85
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Epidemiology (2007) 5.77
Incidence and risk factors for the immune reconstitution inflammatory syndrome in HIV patients in South Africa: a prospective study. AIDS (2008) 4.36
Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies. AIDS (2008) 4.21
Preventable drug-related hospital admissions. Ann Pharmacother (2002) 3.78
A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals. J Acquir Immune Defic Syndr (2009) 3.76
Illustrating bias due to conditioning on a collider. Int J Epidemiol (2009) 3.54
First trimester paroxetine use and the prevalence of congenital, specifically cardiac, defects: a meta-analysis of epidemiological studies. Birth Defects Res A Clin Mol Teratol (2010) 3.45
The global prevalence of glucose-6-phosphate dehydrogenase deficiency: a systematic review and meta-analysis. Blood Cells Mol Dis (2009) 3.44
Community Outbreak of HIV Infection Linked to Injection Drug Use of Oxymorphone--Indiana, 2015. MMWR Morb Mortal Wkly Rep (2015) 3.18
Duration of immunity against pertussis after natural infection or vaccination. Pediatr Infect Dis J (2005) 3.14
The ongoing tyranny of statistical significance testing in biomedical research. Eur J Epidemiol (2010) 3.10
Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysis. Am J Epidemiol (2008) 2.91
Living with p values: resurrecting a Bayesian perspective on frequentist statistics. Epidemiology (2013) 2.86
Transmission of Bordetella pertussis to young infants. Pediatr Infect Dis J (2007) 2.77
Comparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective study. PLoS Med (2011) 2.76
Immune reconstitution inflammatory syndrome (IRIS): review of common infectious manifestations and treatment options. AIDS Res Ther (2007) 2.65
Is HIV infection a risk factor for multi-drug resistant tuberculosis? A systematic review. PLoS One (2009) 2.51
Long term outcomes of antiretroviral therapy in a large HIV/AIDS care clinic in urban South Africa: a prospective cohort study. J Int AIDS Soc (2009) 2.44
Neonatal candidemia and end-organ damage: a critical appraisal of the literature using meta-analytic techniques. Pediatrics (2003) 2.38
Lower low-density lipoprotein cholesterol levels are associated with Parkinson's disease. Mov Disord (2007) 2.24
The effect of highly active antiretroviral therapy on the survival of HIV-infected children in a resource-deprived setting: a cohort study. PLoS Med (2011) 2.06
Effect on mortality and virological response of delaying antiretroviral therapy initiation in children receiving tuberculosis treatment. AIDS (2010) 1.99
Anti-retroviral therapy reduces incident tuberculosis in HIV-infected children. Int J Epidemiol (2009) 1.96
Temporal trends in presentation and survival for HIV-associated lymphoma in the antiretroviral therapy era. J Natl Cancer Inst (2013) 1.96
Mortality and associated factors after initiation of pediatric antiretroviral treatment in the Democratic Republic of the Congo. Pediatr Infect Dis J (2009) 1.91
Third-generation chemotherapy agents in the treatment of advanced non-small cell lung cancer: a meta-analysis. J Thorac Oncol (2007) 1.86
Patient retention from HIV diagnosis through one year on antiretroviral therapy at a primary health care clinic in Johannesburg, South Africa. J Acquir Immune Defic Syndr (2013) 1.77
Perinatal exposure to hazardous air pollutants and autism spectrum disorders at age 8. Epidemiology (2010) 1.75
Time to treatment and patient outcomes among TB suspects screened by a single point-of-care xpert MTB/RIF at a primary care clinic in Johannesburg, South Africa. PLoS One (2013) 1.71
A time-series analysis of air pollution and preterm birth in Pennsylvania, 1997-2001. Environ Health Perspect (2005) 1.70
A systematic review and meta-regression of temporal trends in adult CD4(+) cell count at presentation to HIV care, 1992-2011. Clin Infect Dis (2013) 1.67
Bounding causal effects under uncontrolled confounding using counterfactuals. Epidemiology (2005) 1.67
Epidemiologic measures of the course and outcome of pregnancy. Epidemiol Rev (2002) 1.62
Effect of cotrimoxazole on mortality in HIV-infected adults on antiretroviral therapy: a systematic review and meta-analysis. Bull World Health Organ (2011) 1.61
"What they wanted was to give birth; nothing else": barriers to retention in option B+ HIV care among postpartum women in South Africa. J Acquir Immune Defic Syndr (2014) 1.59
Gender difference in HIV RNA levels: a meta-analysis of published studies. J Acquir Immune Defic Syndr (2002) 1.59
IGF-I and IGFBP-3 polymorphisms in relation to circulating levels among African American and Caucasian women. Cancer Epidemiol Biomarkers Prev (2009) 1.58
Loss to follow-up before and after delivery among women testing HIV positive during pregnancy in Johannesburg, South Africa. Trop Med Int Health (2013) 1.58
Implementation of Xpert MTB/RIF for routine point-of-care diagnosis of tuberculosis at the primary care level. S Afr Med J (2012) 1.58
Effect of pulmonary tuberculosis on mortality in patients receiving HAART. AIDS (2009) 1.56
Improved estimation of controlled direct effects in the presence of unmeasured confounding of intermediate variables. Stat Med (2005) 1.51
Comparison of serological and real-time PCR assays to diagnose Bordetella pertussis infection in 2007. J Clin Microbiol (2008) 1.51
Nonexperimental comparative effectiveness research using linked healthcare databases. Epidemiology (2011) 1.50
Implementing early infant diagnosis of HIV infection at the primary care level: experiences and challenges in Malawi. Bull World Health Organ (2012) 1.48
"Toward a clearer definition of confounding" revisited with directed acyclic graphs. Am J Epidemiol (2012) 1.48
"They have already thrown away their chicken": barriers affecting participation by HIV-infected women in care and treatment programs for their infants in Blantyre, Malawi. AIDS Care (2012) 1.47
Neurodevelopment in perinatally HIV-infected children: a concern for adolescence. J Int AIDS Soc (2013) 1.46
Estimating personal exposures from ambient air pollution measures: using meta-analysis to assess measurement error. Epidemiology (2014) 1.45
Experimental demonstration of continuous electronic structure tuning via strain in atomically thin MoS2. Nano Lett (2013) 1.38
Systematic review evaluating the timing of thoracic radiation therapy in combined modality therapy for limited-stage small-cell lung cancer. J Clin Oncol (2004) 1.37
Utility of International Classification of Diseases, Ninth Revision, Clinical Modification codes for communicable disease surveillance. Am J Epidemiol (2010) 1.36
Conditions for bias from differential left truncation. Am J Epidemiol (2006) 1.35
Causal inference from randomized trials in social epidemiology. Soc Sci Med (2003) 1.35
Decreased Ebola Transmission after Rapid Response to Outbreaks in Remote Areas, Liberia, 2014. Emerg Infect Dis (2015) 1.33
APOE-[epsilon]2 allele associated with higher prevalence of sporadic Parkinson disease. Neurology (2004) 1.30
Tuberculosis treatment and risk of stavudine substitution in first-line antiretroviral therapy. Clin Infect Dis (2009) 1.30
Association of multiple anthropometrics of overweight and obesity with incident heart failure: the Atherosclerosis Risk in Communities study. Circ Heart Fail (2009) 1.30
Comparison and temporal trends of three groups with cryptococcosis: HIV-infected, solid organ transplant, and HIV-negative/non-transplant. PLoS One (2012) 1.30
Family history of cancer and incidence of acute leukemia in adults. Am J Epidemiol (2002) 1.26
Patterns of persistent genital human papillomavirus infection among women worldwide: a literature review and meta-analysis. Int J Cancer (2012) 1.23
Meta-analysis of diagnostic accuracy studies accounting for disease prevalence: alternative parameterizations and model selection. Stat Med (2009) 1.22
Initiating antiretroviral therapy when presenting with higher CD4 cell counts results in reduced loss to follow-up in a resource-limited setting. AIDS (2013) 1.20
Estimating error in using ambient PM2.5 concentrations as proxies for personal exposures: a review. Epidemiology (2010) 1.19
Accuracy of fetal growth indicators as surrogate measures of steroid hormone levels during pregnancy. Am J Epidemiol (2003) 1.18
Implementation of a safer conception service for HIV-affected couples in South Africa. AIDS (2014) 1.17
Detecting drug-resistant tuberculosis: the importance of rapid testing. Mol Diagn Ther (2011) 1.16
N-acetylcysteine for the prevention of radiocontrast induced nephropathy: a meta-analysis of prospective controlled trials. J Am Soc Nephrol (2004) 1.12
Common problems related to the use of number needed to treat. J Clin Epidemiol (2009) 1.12
Apolipoprotein E and dementia in Parkinson disease: a meta-analysis. Arch Neurol (2006) 1.11
Six-month gain in weight, height, and CD4 predict subsequent antiretroviral treatment responses in HIV-infected South African children. AIDS (2010) 1.11
Diagnosis of pertussis: a historical review and recent developments. Expert Rev Mol Diagn (2006) 1.08
Daily siesta, cardiovascular risk factors, and measures of subclinical atherosclerosis: results of the Heinz Nixdorf Recall Study. Sleep (2007) 1.08
Extrapulmonary tuberculosis, human immunodeficiency virus, and foreign birth in North Carolina, 1993 - 2006. BMC Public Health (2008) 1.07
Xpert MTB/RIF as a measure of sputum bacillary burden. Variation by HIV status and immunosuppression. Am J Respir Crit Care Med (2014) 1.06
Preventing vertical transmission of HIV in Kinshasa, Democratic Republic of the Congo: a baseline survey of 18 antenatal clinics. Bull World Health Organ (2006) 1.05
NeuroAIDS in Africa. J Neurovirol (2010) 1.05
[Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration]. Gac Sanit (2009) 1.05
Steroid hormone levels during pregnancy and incidence of maternal breast cancer. Cancer Epidemiol Biomarkers Prev (2002) 1.05
Choice of exposure scores for categorical regression in meta-analysis: a case study of a common problem. Cancer Causes Control (2005) 1.04
The potentially modifiable burden of incident heart failure due to obesity: the atherosclerosis risk in communities study. Am J Epidemiol (2010) 1.04
Lead editorial: The need for greater perspective and innovation in epidemiology. Epidemiol Perspect Innov (2004) 1.04
State policies targeting junk food in schools: racial/ethnic differences in the effect of policy change on soda consumption. Am J Public Health (2011) 1.04
Multiple human papillomavirus infections and type competition in men. J Infect Dis (2011) 1.02
Prenatal environmental tobacco smoke exposure and early childhood body mass index. Paediatr Perinat Epidemiol (2010) 1.02
Central nervous system compartmentalization of HIV-1 subtype C variants early and late in infection in young children. PLoS Pathog (2012) 1.01
Exposure to fine particulate matter during pregnancy and risk of preterm birth among women in New Jersey, Ohio, and Pennsylvania, 2000-2005. Environ Health Perspect (2014) 1.01
Baseline assessment of collaborative tuberculosis/HIV activities in Kinshasa, the Democratic Republic of Congo. Trop Doct (2008) 1.01
Completeness of communicable disease reporting, North Carolina, USA, 1995-1997 and 2000-2006. Emerg Infect Dis (2011) 1.00
Linkage to care and treatment for TB and HIV among people newly diagnosed with TB or HIV-associated TB at a large, inner city South African hospital. PLoS One (2013) 0.97
Integration and task shifting for TB/HIV care and treatment in highly resource-scarce settings: one size may not fit all. J Acquir Immune Defic Syndr (2014) 0.97
Adult vaccination strategies for the control of pertussis in the United States: an economic evaluation including the dynamic population effects. PLoS One (2009) 0.97
Estimating error in using residential outdoor PM2.5 concentrations as proxies for personal exposures: a meta-analysis. Environ Health Perspect (2010) 0.97
Assessing exposure in epidemiologic studies to disinfection by-products in drinking water: report from an international workshop. Environ Health Perspect (2002) 0.96
Clinical heterogeneity in systematic reviews and health technology assessments: synthesis of guidance documents and the literature. Int J Technol Assess Health Care (2012) 0.96
HIV-1 protease inhibitors and clinical malaria: a secondary analysis of the AIDS Clinical Trials Group A5208 study. Antimicrob Agents Chemother (2011) 0.96
Training health care workers to promote HIV services for patients with tuberculosis in the Democratic Republic of Congo. Hum Resour Health (2009) 0.95